- Home
- ATYR vs MG Comparison
ATYR vs MG Comparison
Compare ATYR & MG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATYR
- MG
- Stock Information
- Founded
- ATYR 2005
- MG 1978
- Country
- ATYR United States
- MG United States
- Employees
- ATYR N/A
- MG N/A
- Industry
- ATYR Biotechnology: Biological Products (No Diagnostic Substances)
- MG Military/Government/Technical
- Sector
- ATYR Health Care
- MG Consumer Discretionary
- Exchange
- ATYR Nasdaq
- MG Nasdaq
- Market Cap
- ATYR 290.6M
- MG N/A
- IPO Year
- ATYR 2015
- MG 2009
- Fundamental
- Price
- ATYR $3.34
- MG $7.79
- Analyst Decision
- ATYR Strong Buy
- MG
- Analyst Count
- ATYR 6
- MG 0
- Target Price
- ATYR $18.60
- MG N/A
- AVG Volume (30 Days)
- ATYR 1.1M
- MG 116.6K
- Earning Date
- ATYR 05-07-2025
- MG 05-07-2025
- Dividend Yield
- ATYR N/A
- MG N/A
- EPS Growth
- ATYR N/A
- MG N/A
- EPS
- ATYR N/A
- MG 0.47
- Revenue
- ATYR N/A
- MG $706,813,000.00
- Revenue This Year
- ATYR $551.06
- MG $5.76
- Revenue Next Year
- ATYR $2,144.84
- MG $2.88
- P/E Ratio
- ATYR N/A
- MG $16.52
- Revenue Growth
- ATYR N/A
- MG N/A
- 52 Week Low
- ATYR $1.42
- MG $7.06
- 52 Week High
- ATYR $4.66
- MG $12.44
- Technical
- Relative Strength Index (RSI)
- ATYR 51.21
- MG 27.60
- Support Level
- ATYR $3.06
- MG $8.87
- Resistance Level
- ATYR $3.67
- MG $9.70
- Average True Range (ATR)
- ATYR 0.25
- MG 0.40
- MACD
- ATYR 0.01
- MG -0.04
- Stochastic Oscillator
- ATYR 46.77
- MG 27.65
About ATYR aTyr Pharma Inc. Common Stock
aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.